Solodyn Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
Conditions:   Sickle Cell Disease;   Cognitive Impairment;   Cognitive Decline;   Cognitive Change;   Cognitive Dysfunction;   Cognitive Deficit;   Neuroinflammatory Response Interventions:   Drug: Minocycline;   Drug: Placebo Sponsor:   University of Cincinnati Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2022 Category: Research Source Type: clinical trials